
ELV Stock Forecast & Price Target
ELV Analyst Ratings
Bulls say
Elevance Health is in a strong financial position as it remains the largest single provider for Blue Cross Blue Shield branded coverage in 14 states, with the potential to expand through acquisitions and penetration in government-sponsored programs. The company's unique position and broad diversification provide opportunities for growth, and its commitment to >12% EPS growth in 2027 reflects confidence in its long-term prospects. Valuation is attractive given the multiple expansion potential, and management's commitment to improving margins and achieving sustainable earnings growth through rate catch-ups, disciplined pricing, and M&A.
Bears say
Elevance Health is facing downside risks in their commercial market due to increasing pressure and potential adverse regulatory/legislative changes. The company's ability to control medical costs may also be hindered, and they may face challenges in growing their government pay and PBM businesses. This could result in a decrease in membership and a decrease in margins in the coming years. Additionally, the company's investments in AI/tech and scalability could also lead to a negative impact on earnings in the short term.
This aggregate rating is based on analysts' research of Elevance Health Inc and is not a guaranteed prediction by Public.com or investment advice.
ELV Analyst Forecast & Price Prediction
Start investing in ELV
Order type
Buy in
Order amount
Est. shares
0 shares